Stockreport

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF 2 diabetes medications, by providing long-term therapeutic delivery of exenatide for six months Study will represent first clinical application of NanoPortalâ„¢, the com [Read more]